✦ LIBER ✦

Efficacy Analysis of Immune Globulin Subcutaneous (Human), 10% (IGSC) Administered Intravenously or Subcutaneously in Subjects with Primary Immunodeficiency Diseases (PIDD)

✍ Scribed by Schiff, R.I.; Wasserman, R.L.; Melamed, I.; Stein, M.; Engl, W.; Leibl, H.; Gelmont, D.; Grossman, W.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic Analysis (PK) of Immune

✍ Leibl, H.; Wasserman, R.L.; Melamed, I.; Stein, M.; Engl, W.; Schiff, R.I.; Gelm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

New Immune Globulin Subcutaneous (Human)

✍ Grossman, W.J.; Wasserman, R.L.; Melamed, I.; Stein, M.; Engl, W.; Leibl, H.; Sc 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Pharmacokinetics (PK) of Human Immunoglo

✍ Stein, M.; Wasserman, R.L.; Melamed, I.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Efficacy, Safety, and Pharmacokinetics o

✍ Richard L. Wasserman; Isaac Melamed; Lisa Kobrynski; Steven D. Strausbaugh; Mark 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 213 KB

Pharmacokinetics (PK) of Human Immunoglo

✍ Rubinstein, A.; Wasserman, R.L.; Melamed, I.; Stein, M.; McCoy, B.; Engl, W.; Le 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Tolerability and Efficacy of Facilitated

✍ Wasserman, R.L.; Melamed, I.; Stein, M.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 41 KB